247 related articles for article (PubMed ID: 25341419)
1. Plasmodium falciparum M1-aminopeptidase: a promising target for the development of antimalarials.
González-Bacerio J; Fando R; del Monte-Martínez A; Charli JL; Chávez Mde L
Curr Drug Targets; 2014; 15(12):1144-65. PubMed ID: 25341419
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships and blood distribution of antiplasmodial aminopeptidase-1 inhibitors.
Deprez-Poulain R; Flipo M; Piveteau C; Leroux F; Dassonneville S; Florent I; Maes L; Cos P; Deprez B
J Med Chem; 2012 Dec; 55(24):10909-17. PubMed ID: 23176597
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
[TBL] [Abstract][Full Text] [Related]
4. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
[TBL] [Abstract][Full Text] [Related]
5. Metalloaminopeptidases of the Protozoan Parasite
Mills B; Isaac RE; Foster R
J Med Chem; 2021 Feb; 64(4):1763-1785. PubMed ID: 33534577
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of plasmodial aminopeptidase: a combined molecular docking and QSAR-based in silico approaches.
Wang F; Hu X; Zhou B
Mol Divers; 2019 Nov; 23(4):965-984. PubMed ID: 30730017
[TBL] [Abstract][Full Text] [Related]
7. Potent dual inhibitors of Plasmodium falciparum M1 and M17 aminopeptidases through optimization of S1 pocket interactions.
Drinkwater N; Vinh NB; Mistry SN; Bamert RS; Ruggeri C; Holleran JP; Loganathan S; Paiardini A; Charman SA; Powell AK; Avery VM; McGowan S; Scammells PJ
Eur J Med Chem; 2016 Mar; 110():43-64. PubMed ID: 26807544
[TBL] [Abstract][Full Text] [Related]
8. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; Ribacke U; Lukens AK; Santos SA; Patel V; Clish CB; Sullivan WJ; Zhou H; Bopp SE; Schimmel P; Lindquist S; Clardy J; Mota MM; Keller TL; Whitman M; Wiest O; Wirth DF; Mazitschek R
Sci Transl Med; 2015 May; 7(288):288ra77. PubMed ID: 25995223
[TBL] [Abstract][Full Text] [Related]
9. The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum.
Teuscher F; Lowther J; Skinner-Adams TS; Spielmann T; Dixon MW; Stack CM; Donnelly S; Mucha A; Kafarski P; Vassiliou S; Gardiner DL; Dalton JP; Trenholme KR
J Biol Chem; 2007 Oct; 282(42):30817-26. PubMed ID: 17720817
[TBL] [Abstract][Full Text] [Related]
10. The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria.
Skinner-Adams TS; Peatey CL; Anderson K; Trenholme KR; Krige D; Brown CL; Stack C; Nsangou DM; Mathews RT; Thivierge K; Dalton JP; Gardiner DL
Antimicrob Agents Chemother; 2012 Jun; 56(6):3244-9. PubMed ID: 22450967
[TBL] [Abstract][Full Text] [Related]
11. Screening the Medicines for Malaria Venture "Malaria Box" against the Plasmodium falciparum aminopeptidases, M1, M17 and M18.
Paiardini A; Bamert RS; Kannan-Sivaraman K; Drinkwater N; Mistry SN; Scammells PJ; McGowan S
PLoS One; 2015; 10(2):e0115859. PubMed ID: 25700165
[TBL] [Abstract][Full Text] [Related]
12. Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases.
McGowan S; Oellig CA; Birru WA; Caradoc-Davies TT; Stack CM; Lowther J; Skinner-Adams T; Mucha A; Kafarski P; Grembecka J; Trenholme KR; Buckle AM; Gardiner DL; Dalton JP; Whisstock JC
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2449-54. PubMed ID: 20133789
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials.
Skinner-Adams TS; Stack CM; Trenholme KR; Brown CL; Grembecka J; Lowther J; Mucha A; Drag M; Kafarski P; McGowan S; Whisstock JC; Gardiner DL; Dalton JP
Trends Biochem Sci; 2010 Jan; 35(1):53-61. PubMed ID: 19796954
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of PfA-M1, over PfA-M17, by an amino-benzosuberone derivative blocks malaria parasites development in vitro and in vivo.
Bounaadja L; Schmitt M; Albrecht S; Mouray E; Tarnus C; Florent I
Malar J; 2017 Sep; 16(1):382. PubMed ID: 28934959
[TBL] [Abstract][Full Text] [Related]
15. Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.
Flipo M; Beghyn T; Leroux V; Florent I; Deprez BP; Deprez-Poulain RF
J Med Chem; 2007 Mar; 50(6):1322-34. PubMed ID: 17326615
[TBL] [Abstract][Full Text] [Related]
16. Aminopeptidases of malaria parasites: new targets for chemotherapy.
Trenholme KR; Brown CL; Skinner-Adams TS; Stack C; Lowther J; To J; Robinson MW; Donnelly SM; Dalton JP; Gardiner DL
Infect Disord Drug Targets; 2010 Jun; 10(3):217-25. PubMed ID: 20334618
[TBL] [Abstract][Full Text] [Related]
17. Mapping the Pathway and Dynamics of Bestatin Inhibition of the Plasmodium falciparum M1 Aminopeptidase PfA-M1.
Yang W; Riley BT; Lei X; Porebski BT; Kass I; Buckle AM; McGowan S
ChemMedChem; 2018 Dec; 13(23):2504-2513. PubMed ID: 30318749
[TBL] [Abstract][Full Text] [Related]
18. High-level expression in Escherichia coli, purification and kinetic characterization of Plasmodium falciparum M1-aminopeptidase.
González-Bacerio J; Osuna J; Ponce A; Fando R; Figarella K; Méndez Y; Charli JL; Chávez Mde L
Protein Expr Purif; 2014 Dec; 104():103-14. PubMed ID: 25123643
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual Screening.
Ruggeri C; Drinkwater N; Sivaraman KK; Bamert RS; McGowan S; Paiardini A
PLoS One; 2015; 10(9):e0138957. PubMed ID: 26406322
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibitors of the Plasmodium falciparum electron transport chain.
Stocks PA; Barton V; Antoine T; Biagini GA; Ward SA; O'Neill PM
Parasitology; 2014 Jan; 141(1):50-65. PubMed ID: 24401337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
